Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.

MLA

Kemp, Zoe, et al. “Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.” JAMA Network Open, vol. 2, no. 5, May 2019, p. e194428. EBSCOhost, https://doi.org/10.1001/jamanetworkopen.2019.4428.

APA

Kemp, Z., Turnbull, A., Yost, S., Seal, S., Mahamdallie, S., Poyastro-Pearson, E., Warren-Perry, M., Eccleston, A., Tan, M.-M., Teo, S. H., Turner, N., Strydom, A., George, A., & Rahman, N. (2019). Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer. JAMA Network Open, 2(5), e194428. https://doi.org/10.1001/jamanetworkopen.2019.4428

Chicago

Kemp, Zoe, Alice Turnbull, Shawn Yost, Sheila Seal, Shazia Mahamdallie, Emma Poyastro-Pearson, Margaret Warren-Perry, et al. 2019. “Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.” JAMA Network Open 2 (5): e194428. doi:10.1001/jamanetworkopen.2019.4428.